Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
Gilead Sciences wins 2025 Prix Galien USA Award for Best Pharmaceutical Product for Yeztugo: Foster City, California Monday, November 3, 2025, 17:00 Hrs [IST] Gilead Sciences, Inc ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Genomics, a science-led techbio company using large-scale genetic information to develop innovative precision healthcare tools and to accelerate drug discovery and development, has today announced new ...
For the first time, thanks to CRISPR scissors, the genome of reptiles has been edited. American researchers have managed to ...
A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Hosted on MSN
Researchers make major progress toward curing HIV
On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ongoing battle against the virus. This breakthrough builds on a series of ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback